Predictive  factors Frequency No. evenement HR P 95%CI
Sex      
Male 38(88.37) 12(31.58) 1.086 0.894 0.324-3.640
Female 5(11.63) 3(60)
Age      
< 60 15(34.88) 4(26.66) 0.933 0.873 0.399-2.181   
 ≥ 60 28(65.12) 11(39.29)
Multiplicity      
Simple 26(60.47) 8(30.77) 1.308 0.536 0.560-3.056
Multiple 17(39.53) 7(41.18)
Tumor size      
  <3cm 17(39.53) 7(41.18) 0.918 0.838 0.402-2.097
 ≥3cm 26(60.47) 8(30.77)
Stage      
  pTa 20(46.51) 6(30) 0.821 0.635 0.365-1.849
pT1 23(53.49) 9(39.13)
Grade             
Low 30(69.78) 10(33.33) 1.123 0.737 0.571-2.211
High 13(30.24) 5(38.46)
HSP90 expression      
Low 5(11.6) 3(12.5) 1.086 0.894 0.324-3.640
High   21(87.5)    
Abbreviations: HR: Hasard Ratio; 95%CI :Confiance Interval ; p< 0.05 is significant.
Table 2: Univariate Cox regression analysis to predict time to recurrence following end of treatment.